Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients
Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients
Recruiting · NCT07114627 · Registry updated 2025-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients | Chemically-Induced Disorders, Digestive System Diseases, Digestive System Neoplasms, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, colonic disorder, colorectal neoplasm, dermatitis, digestive system disorder, digestive system neoplasm, drug allergy, esophageal cancer, esophageal disorder, hand-foot syndrome, intestinal disorder, neoplasm, rectal disorder, skin disorder | Recruiting | Not stated | 2025-08-11 | NCT07114627 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Erasmus Medical Center | 271 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Erasmus MC Cancer Institute | Rotterdam | Netherlands | 2 |